SULIMAN SHEHNAAZ — SEC insider filings

SEC reporting owner CIK 1713070. 19 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2020-10-05 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Alector, Inc. (ALEC)President and COO4—8 legs · 300,000 sh · $6,646,47512
10x Genomics, Inc. (TXG)Director9—9 legs · 13,653 sh · $791,9029
Ultragenyx Pharmaceutical Inc. (RARE)Director6—1 leg · 5,740 sh · $144,18912

Insider filings — SULIMAN SHEHNAAZ

FiledFormIssuerReported transactionsSource
2026-09-24410x Genomics, Inc. (TXG)Sale (S): 292 @ $78.20 · Sale (S): 614 @ $79.51 · Sale (S): 1,325 @ $80.82 · Sale (S): 2,270 @ $81.67 · Sale (S): 1,222 @ $82.28EDGAR
2026-08-26410x Genomics, Inc. (TXG)Sale (S): 561 @ $62.73 · Sale (S): 1,646 @ $63.97EDGAR
2026-06-18410x Genomics, Inc. (TXG)Sale (S): 5,359 @ $32.59 · Sale (S): 364 @ $33.27EDGAR
2026-06-08410x Genomics, Inc. (TXG)Grant/award (A): 8,829 @ $0EDGAR
2026-05-184Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 7,751 @ $0 · Sale (S): 5,740 @ $25.12 · Grant/award (A): 14,058 (derivative) @ $0EDGAR
2025-06-05410x Genomics, Inc. (TXG)Grant/award (A): 15,357 @ $0EDGAR
2025-05-194Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 5,740 @ $0 · Grant/award (A): 10,787 (derivative) @ $0EDGAR
2024-06-204Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 5,345 @ $0 · Grant/award (A): 9,900 (derivative) @ $0EDGAR
2024-06-13410x Genomics, Inc. (TXG)Grant/award (A): 8,649 @ $0EDGAR
2023-06-16410x Genomics, Inc. (TXG)Grant/award (A): 1,865 @ $0 · Grant/award (A): 4,661 (derivative) @ $0EDGAR
2023-06-094Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 3,860 @ $0 · Grant/award (A): 7,110 (derivative) @ $0EDGAR
2022-06-284Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 3,300 @ $0 · Grant/award (A): 6,245 (derivative) @ $0EDGAR
2022-06-17410x Genomics, Inc. (TXG)Grant/award (A): 2,120 @ $0 · Grant/award (A): 5,300 (derivative) @ $0EDGAR
2021-12-144Alector, Inc. (ALEC)Option exercise (M): 75,000 @ $17.23 · Sale (S): 66,126 @ $21.69 · Sale (S): 8,874 @ $22.33 · Option exercise (M): 75,000 @ $17.23 · Sale (S): 64,102 @ $21.16 · Sale (S): 10,898 @ $21.73 · +2 moreEDGAR
2021-12-104Alector, Inc. (ALEC)Option exercise (M): 19,813 @ $17.23 · Option exercise (M): 55,187 @ $10.24 · Sale (S): 36,511 @ $22.56 · Sale (S): 38,489 @ $23.01 · Option exercise (M): 75,000 @ $17.23 · Sale (S): 72,357 @ $22.80 · +4 moreEDGAR
2021-06-284Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 2,145 @ $0 · Grant/award (A): 4,125 (derivative) @ $0EDGAR
2021-06-15410x Genomics, Inc. (TXG)Grant/award (A): 625 @ $0 · Grant/award (A): 1,563 (derivative) @ $0EDGAR
2021-05-114Alector, Inc. (ALEC)Grant/award (A): 100,000 @ $0EDGAR
2020-10-054Alector, Inc. (ALEC)Grant/award (A): 189,213 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1713070 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs